Clinical Trials

We are currently participating in the following multicenter clinical trials.

 

• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects with Autosomal Dominant Retinitis Pigmentosa due to the P23H mutation in the Rhodopsin RHO gene (AURORA Study)

 

• Rate of Progression in EYS Related Retinal Degeneration (PRO-EYS)

 

• Rate of Progression of PCDH15-Related Retinal degeneration in Usher Syndrome 1F (RUSH1F)

 

We are part of the Foundation for Fighting Blindness FFB multi-center consortium

 

For more information please contact Michele Reg at      mreg4@uky.edu